Welcome to Shaping Tomorrow

Global Scans · test · Weekly Summary


  • Thanks to the robust and diverse pipeline, by 2030, AbbVie is expected to have more than 30 new products or indications approved in China, covering immunology, solid tumour, blood cancer eye care, neuroscience and aesthetics. SHINE
  • With a massive pipeline in neuroscience, specifically Alzheimer's treatments, many analysts predict they will climb several spots in the pharmaceutical industry rankings by 2030. Global Healthcare Magazine
  • As the experts in brain health, neurologists will ask lawmakers to maintain strong federal support for neuroscience research, including the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. EurekAlert!
  • The pipeline breadth is impressive - 19 NMEs by 2030 spanning oncology, neuroscience, cardiometabolic, immunology, and gene therapy. SyneticX
  • By 2035, advancements in quantum computing and neuroscience will converge to create the first rudimentary forms of quantum consciousness. Ian Khan, FutureSHIFT Experience Keynote & Workshop -
  • Pure-play psychedelic developers offer asymmetric upside tied to discrete clinical and regulatory inflection points, while larger neuroscience companies provide a more measured way to participate in innovation with lower binary risk. Gainify
  • A study published in Nature Nanotechnology presents an innovative graphene-based neurotechnology with the potential for a transformative impact in neuroscience and medical applications. ScienceDaily
  • Regulatory scrutiny will remain elevated across immunology, neuroscience and aesthetics as AbbVie expands its pipeline and category exposure. Gainify
  • While headline transactions in 2025 have set ambitious benchmarks, industry watchers will be scrutinising which sectors - neuroscience, oncology, or beyond are poised for further M&A activity. Pharmaceutical Technology
  • AbbVie announced it broke ground on a $195 million state-of-the-art active pharmaceutical ingredient (API) facility that will manufacture immunology, oncology and neuroscience medicines. / USA Cision PR Newswire
  • We are entering an era where AI-driven automation, human-machine interfaces, and neuroscience will redefine industries and societies. openpr
  • With existing customers including Vitality, PwC and Siemens, Arctic Shores harnesses cognitive neuroscience to reveal true potential and soft skills capabilities, fostering greater workforce diversity and quality. RealWire
  • In 2025, a transformative opportunity awaits aspiring neuroscientists: the $7,500 Neuroscience Visionaries Scholarship in the United States. PickAScholarship.com
  • Even Johnson & Johnson, which aims to become the number one company in neuroscience by 2030, axed a Phase III trial in major depressive disorder. BioSpace
  • Modern neuroscience has become so advanced that truly terrifying mind weapons could be created. Technocracy News
  • The problems connected with artificial intelligence and neuroscience will be the most important part of the next five years. TechCrunch
  • Eventually, interfaces might disappear through brain-computer interfaces now under development by companies like Neuralink, Synchron and Precision Neuroscience. Forbes

Last updated: 19 June 2026



Please stand by...

The magic is happening, but it might take a couple of minutes.

Login